Abstract Background/Objectives: Colorectal cancer (CRC) remains a significant global health concern, with limited treatment options for metastatic stage 4 CRC.…
Abstract The anti–PD-L1 atezolizumab has limited efficacy in TNBC. The authors show that combining atezolizumab with cannabidiol enhances PD-L1 expression…
Abstract Simple Summary: Cannabidiol (CBD), one of the compounds present in the marijuana plant, has antitumor properties. However, the effect…
Abstract According to recent studies, Cannabidiol (CBD), one of the main components of Cannabis sativa, has anticancer effects in several…
Abstract Although oxaliplatin is an effective chemotherapeutic drug for colorectal cancer (CRC) treatment, patients often develop resistance to it. Therefore,…
Abstract Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases…